You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

AZD2281

Showing 101 - 109 of 109
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Tumor Metastasis Trial in Manchester, Oxford (AZD2281, Bevacizumab)

Completed
  • Neoplasm Metastasis
  • Manchester, United Kingdom
  • +1 more
Jan 13, 2015

Colorectal Cancer Trial in United States (olaparib)

Completed
Has Results
  • Colorectal Cancer
  • Los Angeles, California
  • +7 more
Sep 22, 2016

Pancreatic Tumors Trial in United Kingdom, United States (KU-0059436 (AZD2281)(PARP inhibitor), Gemcitabine)

Completed
  • Pancreatic Neoplasms
  • New York, New York
  • +3 more
Dec 19, 2013

Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer Trial in Boston (Olaparib)

Withdrawn
  • Ovarian Cancer
  • +2 more
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Aug 18, 2012

Carcinoma, Squamous Cell Trial (olaparib, cisplatin, Intensity Modulated Radiotherapy)

Withdrawn
  • Carcinoma, Squamous Cell
  • (no location specified)
May 29, 2012

Malignant Solid Tumors Trial in Glasgow, Leicester, Manchester (KU-0059436 (AZD2281)(PARP inhibitor), Topotecan)

Completed
  • Malignant Solid Tumors
  • Glasgow, United Kingdom
  • +2 more
Dec 7, 2010

Advanced Solid Malignancies Trial in Tokyo (KU-0059436 (AZD2281)(PARP inhibitor))

Completed
  • Advanced Solid Malignancies
  • KU-0059436 (AZD2281)(PARP inhibitor)
  • Tokyo, Japan
    Research Site
Aug 19, 2009

Melanoma Tumors Trial in United Kingdom, United States (KU-0059436 (AZD2281)(PARP inhibitor), dacarbazine)

Completed
  • Melanoma Neoplasms
  • Pittsburgh, Pennsylvania
  • +3 more
May 14, 2009

Tumor Metastasis Trial in London (AZD2281)

Completed
  • Neoplasm Metastasis
  • AZD2281
  • London, United Kingdom
    Research Site
Jan 13, 2009